Ocular Therapeutix Stock Market Value
| OCUL Stock | USD 10.06 0.31 3.18% |
| Symbol | Ocular |
Ocular Therapeutix Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share 0.529 | Quarterly Revenue Growth 0.083 | Return On Assets (0.22) | Return On Equity (0.73) |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocular Therapeutix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ocular Therapeutix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ocular Therapeutix.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Ocular Therapeutix on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Ocular Therapeutix or generate 0.0% return on investment in Ocular Therapeutix over 30 days. Ocular Therapeutix is related to or competes with CytomX Therapeutics, Assembly Biosciences, Spero Therapeutics, Achilles Therapeutics, Terns Pharmaceuticals, Amylyx Pharmaceuticals, and Acumen Pharmaceuticals. Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of... More
Ocular Therapeutix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ocular Therapeutix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ocular Therapeutix upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.14 | |||
| Information Ratio | 0.0242 | |||
| Maximum Drawdown | 19.78 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 6.61 |
Ocular Therapeutix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ocular Therapeutix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ocular Therapeutix's standard deviation. In reality, there are many statistical measures that can use Ocular Therapeutix historical prices to predict the future Ocular Therapeutix's volatility.| Risk Adjusted Performance | 0.0561 | |||
| Jensen Alpha | 0.2002 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0272 | |||
| Treynor Ratio | 2.13 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocular Therapeutix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocular Therapeutix Backtested Returns
Ocular Therapeutix appears to be somewhat reliable, given 3 months investment horizon. Ocular Therapeutix maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1% return per unit of risk over the last 3 months. We have found thirty technical indicators for Ocular Therapeutix, which you can use to evaluate the volatility of the company. Please evaluate Ocular Therapeutix's Coefficient Of Variation of 1585.31, risk adjusted performance of 0.0561, and Semi Deviation of 2.92 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ocular Therapeutix holds a performance score of 8. The company holds a Beta of 0.0999, which implies not very significant fluctuations relative to the market. As returns on the market increase, Ocular Therapeutix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ocular Therapeutix is expected to be smaller as well. Please check Ocular Therapeutix's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Ocular Therapeutix's historical price patterns will revert.
Auto-correlation | 0.05 |
Virtually no predictability
Ocular Therapeutix has virtually no predictability. Overlapping area represents the amount of predictability between Ocular Therapeutix time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ocular Therapeutix price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Ocular Therapeutix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Ocular Therapeutix lagged returns against current returns
Autocorrelation, which is Ocular Therapeutix stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ocular Therapeutix's stock expected returns. We can calculate the autocorrelation of Ocular Therapeutix returns to help us make a trade decision. For example, suppose you find that Ocular Therapeutix has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ocular Therapeutix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ocular Therapeutix stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ocular Therapeutix stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ocular Therapeutix stock over time.
Current vs Lagged Prices |
| Timeline |
Ocular Therapeutix Lagged Returns
When evaluating Ocular Therapeutix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ocular Therapeutix stock have on its future price. Ocular Therapeutix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ocular Therapeutix autocorrelation shows the relationship between Ocular Therapeutix stock current value and its past values and can show if there is a momentum factor associated with investing in Ocular Therapeutix.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Ocular Therapeutix Correlation, Ocular Therapeutix Volatility and Ocular Therapeutix Alpha and Beta module to complement your research on Ocular Therapeutix. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Ocular Therapeutix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.